UPDATE: J.P. Morgan Downgrades Teva Pharmaceutical on Too Much ...

04-11-2013 BenzingaComments (0)

PharmaceuticalTeva Pharmaceutical Industries

In a report published Monday, J.P. Morgan analyst Chris Schott downgraded the rating on Teva Pharmaceutical (NYSE: TEVA) from Neutral to Underweight, and lowered the price target from $43.00 to $38.00. In the report, J.P. Morgan noted, “We are ...

Read more on Benzinga

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top